University of Queensland to establish world-leading mRNA lab

mRNA vaccines and therapies will be produced for clinical trials in a dedicated laboratory to be established at The University of Queensland as demand for mRNA continues to surge.

Work is underway at UQ’s BASE facility which has become Australia’s leading provider of mRNA for research and pilot studies since its launch in 2021.

The Commonwealth Government’s Medical Research Future Fund (MRFF) National Critical Research Infrastructure scheme will contribute $4.3 million, with global healthcare company and partner Sanofi and UQ each committing $1 million, and the Queensland Government $250,000.